AccendoWave

AccendoWave is a Pain Data Company utilizing machine learning technology to measure and manage pain. The company, incubated by HCA (188 Hospitals & 5-6% of US Inpatient Care), has garnered support from renowned partners such as Samsung and AT&T. AccendoWave's innovative approach addresses the significant impact of pain on healthcare costs, as traditional data sources like claims or Electronic Health Records do not capture subjective pain levels effectively. Moreover, the company recognizes the pervasive issue of pain bias in healthcare and aims to provide an unbiased medical technology solution to validate patient pain. AccendoWave's technology encompasses full spectrum brain analysis and deep learning algorithms, offering three primary solutions: Digital Opioid Alternative, Remote Pain Monitoring Technology, and the Largest Global Real-Time Benchmarked Objective Database on Pain, comprising Nine Pain Databases. The company creates value for Health Plans, Employers, Hospitals, Government Entities, and Pharma/Biotech Companies by integrating objective pain benchmark data to eliminate bias, improve outcomes, and reduce healthcare costs. Founded in 2012 and headquartered in the United States, AccendoWave presents a compelling opportunity for investment in the biotechnology and healthcare industries with its potential to address critical pain management challenges and drive positive impacts across multiple stakeholders in the healthcare ecosystem.